HER2, a 180 KDa transmembrane glycoprotein, is expressed on the surface of diverse tumor cells, including 20 to 30% of breast cancers [24], 20% of gastric cancers [25], and 12 to 15% of gallbladder cancers [26]. Here, ERBB2 is linked to neoplasm.